-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Development of a generic laboratory manual for biological sample logistics in clinical pharmacokinetic studies
Richard W Abbott, Rebecca Sleigh, Jeff Long, Carina Ekstrom, Bernd Matthes & Jose Groenboom
Nieuwenhuijzen
Opinion Article: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Treatment of polycystic ovary syndrome: recent trial results
Mohd Ashraf Ganie, Semanti Chakraborty & Hammadur Rehman
Clinical Trail Outcomes: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Overview on clinical trials in Waldenstroms macroglobulinemia
Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi & Enrica Morra
Clinical Trail Outcomes: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation